Eliquent Life Sciences completed the acquisition of RApport Global Strategic Services.

Eliquent Life Sciences, a global regulatory consulting firm for the life sciences industry, completed the acquisition of RApport Global Strategic Services, a UK based international regulatory consultancy. Financial terms were not disclosed. “Today’s announcement further positions ELIQUENT as a leader in global regulatory consulting and underscores our commitment to delivering value to our clients. I look forward to partnering with the talented RApport team as we offer our clients an expanded portfolio of solutions designed to streamline market entry and compliance strategies worldwide,” Tim Dietlin, ELIQUENT Life Sciences CEO.